Eventide Asset Management - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 87 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2019$8,561,000
+42.5%
720,000
-37.2%
0.26%
+25.6%
Q1 2019$6,008,000
+66.3%
1,146,5800.0%0.21%
+29.4%
Q4 2018$3,612,0001,146,5800.16%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2018
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders